.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Savvy’s mix tilted toward Flower at 47.6% share while Vapor Pens held 36.9%, with Edible at 14.4% and Pre-Roll at 1.1%. Year over year, Flower contracted 33.0% and Vapor Pens fell 48.0%, while Edible expanded 31.2% and Pre-Roll dropped 69.7%; month over month, Flower declined 25.3% and Vapor Pens decreased 17.1%, with Edible down 7.4% but Pre-Roll up 13.6%. With brand sales down 36.2% year over year and the average price down 21.5%, the pattern implies Savvy is ceding higher-ticket inhalables while leaning into lower-priced Edible growth that is not yet large enough to offset the double-digit Flower and Vapor Pens pullback.
These shifts recast Savvy’s positioning in Illinois Vapor Pens, where a rank of 6 suggests mid-pack presence even as the category mix skews away from that segment; Vapor Pens’ share at 36.9% against a 17.1% month-over-month decline signals weaker velocity relative to Flower’s 25.3% drop and Edible’s 7.4% dip. The 31.2% year-over-year Edible increase alongside a 21.5% average price reduction points to price-led trial that dilutes average revenue per unit, while the 69.7% Pre-Roll decline and 13.6% month-over-month rebound indicate only tactical recovery. The implication is that Savvy must reconcile a price-driven Edible uptick with deteriorating inhalables mix to sustain its rank-6 Vapor Pens foothold and stabilize total share.
Competitive Landscape
Savvy is ranked #6 in IL Vapor Pens in June 2026, down two spots year over year from #4, after also slipping two positions since March 2026 when it held #4; that decline contrasts with RYTHM holding #5 both year over year and in June 2026, and with &Shine maintaining #1 while its sales fell 12.7% year over year. Although Savvy peaked at #3 in December 2025, competitors’ stability at #1 and #5 alongside Savvy’s two-rank YoY drop signals share leakage concentrated in the middle tier, implying the brand is ceding position to steadier incumbents rather than the category leaders.
Notable Products
Guap - Jungle Juice Macro Dosed Gummy (50mg) posted the steepest decline at -20.8% MoM while sliding to rank 6, whereas Guap - Blue Magic Macro Dose Gummy (100mg) fell -15.8% at rank 4, signaling a pullback concentrated in mid-tier Edibles rather than at the very top. In contrast, Guap - Tangie Crush Macro Dose RSO Gummy (100mg) rose +13.7% MoM at rank 2 while Guap - Berry Drip Macro Dose RSO Gummy (100mg) held rank 1 with +3.4%, and together these two top SKUs imply price-insensitive demand for flagship macro-dose gummies even as sub-variants soften. Eight of the top ten are Edible SKUs, yet three Vapor Pens entered the top ten without reported MoM baselines at ranks 8–10, collectively pointing to an incipient mix shift toward inhalables even while Edibles still command the highest ranks and one $296,395 anchor SKU sustains the tier. The pattern suggests Savvy’s commercial direction is bifurcating: flagship macro-dose Edibles concentrate share at the top while secondary gummy variants cede ground, creating room for Vapor Pens to expand as the next leg of category growth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
